Search
Filter by content type
Filter by content year
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR
- PDF Version 154.5 KB
BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China
- PDF Version 153.7 KB
BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
March 16, 2020 - … BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in … China 16 March 2020 All Collaborators General BioNTech and Fosun Pharma will jointly conduct clinical trials of BNT162 …
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR
August 27, 2020 - … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or …
BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China
November 16, 2020 - … BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine … – BioNTech SE (“BioNTech”; Nasdaq: BNTX,) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma”; Stock …
BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China
November 25, 2020 - … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … Lead mRNA COVID-19 Vaccine BNT162b2 in China BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … – BioNTech SE (“BioNTech”; Nasdaq: BNTX,) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma”; Stock …
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
December 16, 2020 - … BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine … (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or …
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
August 5, 2020 - … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or …
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
March 16, 2020 - … BioNTech announced today a strategic alliance with Fosun Pharma to jointly develop its COVID-19 vaccine in … of Pennsylvania, The Bill and Melinda Gates Foundation and Fosun Pharma. About BioNTech Biopharmaceutical New … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
September 17, 2020 - … supply, including to China, where it is partnered with Fosun Pharma, subject to regulatory authorization or … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer and BioNTech and Fosun to develop a potential COVID-19 vaccine; the timing to …
